The global carcinoid syndrome diarrhea treatment market was valued at USD 4.63 billion in 2025 and is projected to grow from USD 5.02 billion in 2026 to USD 9.57 billion by 2034 , registering a CAGR of 8.4% during 2026–2034 . North America dominated the market with a 41.6% share in 2025 , while Asia Pacific is expected to register the fastest CAGR of 8.12% during the forecast period....
